On 27 october 2017, the manufacturer of the ceramic component involved in the complaint (not marketed in us) provided a document review, reporting as follows: the component properties and the microstructure as obtained from the quality documents accomplish the requirements as specified at the time of production.There are no indications of any pre-existing material defect or non-conformities regarding sterilization.Due to lack of ceramic parts further investigations cannot be done.Batch reviews performed on 30 october 2017.(b)(4).To date, all items of the same lot have been already sold without any similar reported event.
|
Revision performed: the stem removed and the surgery went on successfully.Implants are not available for investigation.The stem was completely loose and easy to remove.On the implant was no osseointegration.The surgeon supposes a loosening due to infection, but as long as he didn't get the results, we cannot confirm anything.Clinical investigation (b)(6) by medical affairs director: late infection in cementless tha, 2 years after primary operation.Infection is a known possible adverse event following every surgery, including tha's.To date, there is no reason to suspect that the cause may be linked to the implanted devices.
|